Dupont Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-884
Closed -$192K 721
2023
Q1
$192K Buy
884
+205
+30% +$39.9K 0.01% 466
2022
Q4
$140K Sell
679
-784
-54% -$198K 0.01% 871
2022
Q3
$407K Sell
1,463
-5,691
-80% -$1.45M 0.02% 692
2022
Q2
$1.37M Buy
7,154
+1,612
+29% +$285K 0.06% 333
2022
Q1
$1.15M Buy
5,542
+3,151
+132% +$519K 0.05% 422
2021
Q4
$426K Sell
2,391
-2,571
-52% -$507K 0.02% 867
2021
Q3
$1.02M Sell
4,962
-177
-3% -$34.8K 0.03% 526
2021
Q2
$975K Buy
+5,139
New +$841K 0.02% 621

Other funds holding SWAV

Dupont Capital Management's SWAV Position: Q2 2023 in Review

Dupont Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2023, closing a stake of 884 shares — an estimated $192K sold.

Dupont Capital Management first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $1.37M in Q2 2022. 460 funds tracked by Wall St. Rank hold SWAV as of Q2 2023.

  • Dupont Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dupont Capital Management sold 884 Shockwave Medical, Inc. Common Stock shares in Q2 2023, an estimated $192K.
  • Dupont Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Dupont Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $1.37M in Q2 2022.
  • 460 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.